9 research outputs found
Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in Japan
No full textRegulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA
No full textTrends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
No full text
The use of induced pluripotent stem cells in drug development.
Get PDFInduced pluripotent stem cell (iPSC) technology is revolutionizing medical science, allowing the exploration of disease mechanisms and novel therapeutic molecular targets, and offering opportunities for drug discovery and proof-of-concept studies in drug development. This review focuses on the recent advancements in iPSC technology including disease modeling and control setting in its analytical paradigm. We describe how iPSC technology is integrated into existing paradigms of drug development and discuss the potential of iPSC technology in personalized medicine
Clinical Pharmacology and the Catalysis of Regulatory Science: Opportunities for the Advancement of Drug Development and Evaluation
No full text
